These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16380829)

  • 1. A functional continuum of regulatory anxiety-enhancing peptides. The search for complexes providing the optimal basis for developing inhibitory therapeutic agents.
    Koroleva SV; Ashmarin IP
    Neurosci Behav Physiol; 2006 Feb; 36(2):157-62. PubMed ID: 16380829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional continuum of the regulatory peptides enhancing anxiety. Search for the optimal complexes as a basis for developing inhibitory therapeutic agents].
    Koroleva SV; Ashmarin IP
    Ross Fiziol Zh Im I M Sechenova; 2005 Jan; 91(1):3-11. PubMed ID: 15773576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Searching for the optimal combinations of regulator anxiolytic peptides: theoretical rationale].
    Koroleva SV; Ashmarin IP
    Izv Akad Nauk Ser Biol; 2001; (1):63-73. PubMed ID: 11236582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamic hierarchy of regulatory peptides. Structure of the induction relations of regulators as the target for therapeutic agents].
    Koroleva SV; Miasoedov NF
    Usp Fiziol Nauk; 2012; 43(3):38-47. PubMed ID: 23101378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of neuropeptide Y in anxiety].
    Krysiak R; Obuchowicz E; Herman ZS
    Psychiatr Pol; 2001; 35(5):731-42. PubMed ID: 11842605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional continuum of regulatory peptides (RPs): vector model of RP-effects representation.
    Koroleva SV; Ashmarin IP
    J Theor Biol; 2002 Jun; 216(3):257-71. PubMed ID: 12183118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Easing the burden: treating refractory anxiety.
    Gorman JM
    CNS Spectr; 2004 Oct; 9(10):708. PubMed ID: 15448581
    [No Abstract]   [Full Text] [Related]  

  • 8. Benzodiazepines for treatment of panic attacks: a new look.
    Rickels K; Schweizer EE
    Psychopharmacol Bull; 1986; 22(1):93-9. PubMed ID: 2873621
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuropharmacology of anxiety: perspectives and prospects.
    Hamon M
    Trends Pharmacol Sci; 1994 Feb; 15(2):36-9. PubMed ID: 7909396
    [No Abstract]   [Full Text] [Related]  

  • 10. Anxiogenic-like action of galanin after intra-amygdala administration in the rat.
    Möller C; Sommer W; Thorsell A; Heilig M
    Neuropsychopharmacology; 1999 Oct; 21(4):507-12. PubMed ID: 10481834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein synthesis and the mechanisms of lasting change in anxiety induced by severe stress.
    Adamec R; Strasser K; Blundell J; Burton P; McKay DW
    Behav Brain Res; 2006 Feb; 167(2):270-86. PubMed ID: 16256211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder.
    Gastfriend DR; Rosenbaum JF
    Am J Psychiatry; 1989 Jul; 146(7):914-6. PubMed ID: 2568095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety levels and related pharmacological drug treatment: a memorandum for the third millennium.
    Pasquini M; Berardelli I
    Ann Ist Super Sanita; 2009; 45(2):193-204. PubMed ID: 19636172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of anxiety in the medically ill patient.
    Rubey RN; Lydiard RB
    Semin Clin Neuropsychiatry; 1999 Apr; 4(2):133-47. PubMed ID: 10378956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepines: pros and cons for fear and anxiety.
    Crowell-Davis SL
    Compend Contin Educ Vet; 2008 Oct; 30(10):E1. PubMed ID: 19003774
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of noradrenergic and corticoid receptors in the consolidation of the lasting anxiogenic effects of predator stress.
    Adamec R; Muir C; Grimes M; Pearcey K
    Behav Brain Res; 2007 May; 179(2):192-207. PubMed ID: 17335916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapy of anxiety practice (author's transl)].
    Al-Shaltchi B; Pöldinger W
    Ther Umsch; 1975 Aug; 32(8):486-96. PubMed ID: 240216
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models.
    Stewart A; Wu N; Cachat J; Hart P; Gaikwad S; Wong K; Utterback E; Gilder T; Kyzar E; Newman A; Carlos D; Chang K; Hook M; Rhymes C; Caffery M; Greenberg M; Zadina J; Kalueff AV
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(6):1421-31. PubMed ID: 21122812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.